文献
J-GLOBAL ID:201702242420764675
整理番号:17A1705252
新規脾臓チロシンキナーゼ阻害剤JTE852はin vivoで免疫グロブリンG細胞応答と自己免疫反応を阻害する【Powered by NICT】
JTE-852, a novel spleen tyrosine kinase inhibitor, blocks immunoglobulin G-mediated cellular responses and autoimmune reactions in vivo
著者 (7件):
Kato Toshinobu
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
,
Ohta Takeshi
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
,
Iwasaki Hidenori
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
,
Kobayashi Hatsue
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
,
Matsuo Akira
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
,
Hata Takahiro
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
,
Matsushita Mutsuyoshi
(Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., Osaka, Japan)
資料名:
Life Sciences
(Life Sciences)
巻:
191
ページ:
166-174
発行年:
2017年
JST資料番号:
B0699B
ISSN:
0024-3205
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)